Terazosin Hydrochloride Capsule
Product Images NDC 68788-9816
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 68788-9816). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Preferred Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2 (Fig 2)
Figure3 (Fig 3)
Figure4 (Fig 4)
Terazosin Hydrochloride Capsules 1mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 02)
Terazosin Hydrochloride Capsules 2mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 01)
Terazosin Hydrochloride Capsules 5mg (58fe004c B69e 422e 8089 2ab1b59ceb4c 00)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.